IRIDEX Corporation (IRIX)
USD 0.95
(-7.77%)
USD 0.95
(-7.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 31.81 Million USD | -4.34% |
| 2022 | 32.91 Million USD | 8.38% |
| 2021 | 30.36 Million USD | 37.14% |
| 2020 | 22.14 Million USD | -17.73% |
| 2019 | 26.91 Million USD | -11.29% |
| 2018 | 30.33 Million USD | 6.34% |
| 2017 | 28.53 Million USD | 22.53% |
| 2016 | 23.28 Million USD | 18.4% |
| 2015 | 19.66 Million USD | 4.5% |
| 2014 | 18.81 Million USD | 17.95% |
| 2013 | 15.95 Million USD | -7.28% |
| 2012 | 17.2 Million USD | 19.85% |
| 2011 | 14.35 Million USD | -20.71% |
| 2010 | 18.1 Million USD | 1.98% |
| 2009 | 17.75 Million USD | -18.75% |
| 2008 | 21.85 Million USD | -54.85% |
| 2007 | 48.39 Million USD | 105.34% |
| 2006 | 23.57 Million USD | 44.02% |
| 2005 | 16.36 Million USD | 2.52% |
| 2004 | 15.96 Million USD | 13.07% |
| 2003 | 14.11 Million USD | 2.54% |
| 2002 | 13.76 Million USD | -8.57% |
| 2001 | 15.05 Million USD | -10.92% |
| 2000 | 16.9 Million USD | 21.04% |
| 1999 | 13.96 Million USD | 14.48% |
| 1998 | 12.2 Million USD | 48.78% |
| 1997 | 8.2 Million USD | 22.39% |
| 1996 | 6.7 Million USD | 42.55% |
| 1995 | 4.7 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.66 Million USD | -2.75% |
| 2024 Q2 | 7.69 Million USD | 1.38% |
| 2023 Q3 | 7.3 Million USD | -11.48% |
| 2023 Q1 | 8.28 Million USD | 2.58% |
| 2023 FY | 31.48 Million USD | -4.34% |
| 2023 Q4 | 7.88 Million USD | 7.87% |
| 2023 Q2 | 8.25 Million USD | -0.3% |
| 2022 FY | 32.91 Million USD | 8.38% |
| 2022 Q4 | 8.07 Million USD | -0.99% |
| 2022 Q3 | 8.15 Million USD | -2.67% |
| 2022 Q1 | 8.25 Million USD | -1.73% |
| 2022 Q2 | 8.37 Million USD | 1.51% |
| 2021 Q4 | 8.39 Million USD | 5.79% |
| 2021 FY | 30.36 Million USD | 37.14% |
| 2021 Q1 | 6.78 Million USD | 15.27% |
| 2021 Q2 | 7.24 Million USD | 6.87% |
| 2021 Q3 | 7.93 Million USD | 9.56% |
| 2020 Q1 | 5.56 Million USD | -13.89% |
| 2020 Q2 | 5.19 Million USD | -6.81% |
| 2020 Q3 | 5.5 Million USD | 5.97% |
| 2020 Q4 | 5.88 Million USD | 6.95% |
| 2020 FY | 22.14 Million USD | -17.73% |
| 2019 Q2 | 7.01 Million USD | -3.78% |
| 2019 FY | 26.91 Million USD | -11.29% |
| 2019 Q4 | 6.46 Million USD | 5.39% |
| 2019 Q1 | 7.29 Million USD | -4.22% |
| 2019 Q3 | 6.13 Million USD | -12.56% |
| 2018 Q1 | 7.53 Million USD | 2.53% |
| 2018 Q2 | 7.55 Million USD | 0.15% |
| 2018 Q3 | 7.63 Million USD | 1.14% |
| 2018 Q4 | 7.61 Million USD | -0.29% |
| 2018 FY | 30.33 Million USD | 6.34% |
| 2017 Q1 | 6.32 Million USD | -3.01% |
| 2017 Q2 | 7.23 Million USD | 14.44% |
| 2017 Q4 | 7.35 Million USD | -3.49% |
| 2017 Q3 | 7.61 Million USD | 5.29% |
| 2017 FY | 28.53 Million USD | 22.53% |
| 2016 Q1 | 5.14 Million USD | 2.98% |
| 2016 Q2 | 6.12 Million USD | 19.11% |
| 2016 FY | 23.28 Million USD | 18.4% |
| 2016 Q4 | 6.51 Million USD | 18.7% |
| 2016 Q3 | 5.49 Million USD | -10.38% |
| 2015 FY | 19.66 Million USD | 4.5% |
| 2015 Q2 | 4.96 Million USD | -0.86% |
| 2015 Q1 | 5 Million USD | 1.83% |
| 2015 Q4 | 4.99 Million USD | 6.34% |
| 2015 Q3 | 4.69 Million USD | -5.36% |
| 2014 FY | 18.81 Million USD | 17.95% |
| 2014 Q1 | 4.45 Million USD | -2.96% |
| 2014 Q2 | 4.9 Million USD | 9.91% |
| 2014 Q3 | 4.54 Million USD | -7.29% |
| 2014 Q4 | 4.91 Million USD | 8.23% |
| 2013 Q4 | 4.59 Million USD | 13.18% |
| 2013 Q3 | 4.05 Million USD | 2.32% |
| 2013 Q2 | 3.96 Million USD | 18.99% |
| 2013 Q1 | 3.33 Million USD | -17.33% |
| 2013 FY | 15.95 Million USD | -7.28% |
| 2012 FY | 17.2 Million USD | 19.85% |
| 2012 Q4 | 4.03 Million USD | -10.18% |
| 2012 Q3 | 4.49 Million USD | 0.65% |
| 2012 Q2 | 4.46 Million USD | 5.66% |
| 2012 Q1 | 4.22 Million USD | 367.55% |
| 2011 Q4 | 903 Thousand USD | -79.41% |
| 2011 Q1 | 4.62 Million USD | -1.97% |
| 2011 Q2 | 4.44 Million USD | -3.98% |
| 2011 FY | 14.35 Million USD | -20.71% |
| 2011 Q3 | 4.38 Million USD | -1.28% |
| 2010 FY | 18.1 Million USD | 1.98% |
| 2010 Q4 | 4.71 Million USD | 8.13% |
| 2010 Q2 | 4.4 Million USD | -4.78% |
| 2010 Q3 | 4.36 Million USD | -0.84% |
| 2010 Q1 | 4.62 Million USD | 3.01% |
| 2009 FY | 17.75 Million USD | -18.75% |
| 2009 Q4 | 4.48 Million USD | 8.04% |
| 2009 Q3 | 4.15 Million USD | -6.25% |
| 2009 Q1 | 4.68 Million USD | -14.82% |
| 2009 Q2 | 4.43 Million USD | -5.44% |
| 2008 Q2 | 5.58 Million USD | 0.79% |
| 2008 Q4 | 5.5 Million USD | 5.36% |
| 2008 Q3 | 5.22 Million USD | -6.57% |
| 2008 FY | 21.85 Million USD | -54.85% |
| 2008 Q1 | 5.54 Million USD | -74.83% |
| 2007 Q1 | 10 Million USD | 43.64% |
| 2007 FY | 48.39 Million USD | 105.34% |
| 2007 Q4 | 22.02 Million USD | 204.23% |
| 2007 Q3 | 7.23 Million USD | -20.75% |
| 2007 Q2 | 9.13 Million USD | -8.69% |
| 2006 FY | 23.57 Million USD | 44.02% |
| 2006 Q2 | 5.19 Million USD | 2.57% |
| 2006 Q3 | 6.36 Million USD | 22.5% |
| 2006 Q1 | 5.06 Million USD | 15.54% |
| 2006 Q4 | 6.96 Million USD | 9.5% |
| 2005 Q1 | 3.83 Million USD | -6.51% |
| 2005 Q2 | 3.98 Million USD | 3.94% |
| 2005 Q3 | 4.16 Million USD | 4.39% |
| 2005 Q4 | 4.38 Million USD | 5.26% |
| 2005 FY | 16.36 Million USD | 2.52% |
| 2004 FY | 15.96 Million USD | 13.07% |
| 2004 Q4 | 4.1 Million USD | -15.92% |
| 2004 Q3 | 4.88 Million USD | 32.57% |
| 2004 Q2 | 3.68 Million USD | 11.55% |
| 2004 Q1 | 3.3 Million USD | -11.22% |
| 2003 Q1 | 3.41 Million USD | -2.12% |
| 2003 Q3 | 3.37 Million USD | -6.48% |
| 2003 Q4 | 3.71 Million USD | 10.07% |
| 2003 Q2 | 3.61 Million USD | 5.77% |
| 2003 FY | 14.11 Million USD | 2.54% |
| 2002 Q2 | 3.83 Million USD | 11.66% |
| 2002 Q1 | 3.43 Million USD | -5.82% |
| 2002 FY | 13.76 Million USD | -8.57% |
| 2002 Q4 | 3.48 Million USD | 15.61% |
| 2002 Q3 | 3.01 Million USD | -21.27% |
| 2001 Q4 | 3.64 Million USD | 3.97% |
| 2001 Q3 | 3.5 Million USD | -7.76% |
| 2001 Q2 | 3.8 Million USD | -7.54% |
| 2001 Q1 | 4.11 Million USD | -1.01% |
| 2001 FY | 15.05 Million USD | -10.92% |
| 2000 FY | 16.9 Million USD | 21.04% |
| 2000 Q4 | 4.15 Million USD | -1.19% |
| 2000 Q3 | 4.2 Million USD | -4.3% |
| 2000 Q2 | 4.39 Million USD | 5.5% |
| 2000 Q1 | 4.16 Million USD | 4.94% |
| 1999 Q1 | 3.2 Million USD | -15.79% |
| 1999 FY | 13.96 Million USD | 14.48% |
| 1999 Q4 | 3.96 Million USD | 20.18% |
| 1999 Q3 | 3.3 Million USD | -2.94% |
| 1999 Q2 | 3.4 Million USD | 6.25% |
| 1998 FY | 12.2 Million USD | 48.78% |
| 1998 Q4 | 3.8 Million USD | 35.71% |
| 1998 Q3 | 2.8 Million USD | -6.67% |
| 1998 Q2 | 3 Million USD | 11.11% |
| 1998 Q1 | 2.7 Million USD | 12.5% |
| 1997 Q4 | 2.4 Million USD | 20.0% |
| 1997 FY | 8.2 Million USD | 22.39% |
| 1997 Q2 | 2 Million USD | 11.11% |
| 1997 Q1 | 1.8 Million USD | -25.0% |
| 1997 Q3 | 2 Million USD | 0.0% |
| 1996 FY | 6.7 Million USD | 42.55% |
| 1996 Q1 | - USD | 100.0% |
| 1996 Q2 | 1.5 Million USD | 0.0% |
| 1996 Q3 | 1.5 Million USD | 0.0% |
| 1996 Q4 | 2.4 Million USD | 60.0% |
| 1995 FY | 4.7 Million USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | -7.4 Million USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -183.446% |
| Cerus Corporation | 143.15 Million USD | 77.777% |
| OrthoPediatrics Corp. | 137.01 Million USD | 76.781% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -180.031% |
| Talis Biomedical Corporation | 67.18 Million USD | 52.648% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -27.531% |
| Inogen, Inc. | 236.08 Million USD | 86.524% |
| Spectral AI, Inc. | 20.86 Million USD | -52.483% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 43.186% |
| CVRx, Inc. | 76.14 Million USD | 58.218% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -801.758% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -154.736% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.233% |
| Venus Concept Inc. | 80.47 Million USD | 60.468% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 43.77% |
| Bioventus Inc. | 409.91 Million USD | 92.239% |
| BrainsWay Ltd. | 28.01 Million USD | -13.548% |
| Envoy Medical, Inc. | 17.89 Million USD | -77.752% |
| electroCore, Inc. | 32.03 Million USD | 0.677% |
| IceCure Medical Ltd | 16.87 Million USD | -88.516% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 25.024% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -80.423% |
| MaxCyte, Inc. | 84.84 Million USD | 62.503% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -156.321% |
| Nexalin Technology, Inc. | 5.78 Million USD | -450.286% |
| PAVmed Inc | 64.82 Million USD | 50.925% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 37.715% |
| RxSight, Inc. | 103.85 Million USD | 69.365% |
| Sight Sciences, Inc. | 126.44 Million USD | 74.84% |
| SI-BONE, Inc. | 156.35 Million USD | 79.652% |
| TELA Bio, Inc. | 84.18 Million USD | 62.21% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 54.588% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 84.356% |
| LivaNova PLC | 843.54 Million USD | 96.229% |
| 908 Devices Inc. | 68.08 Million USD | 53.27% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 93.421% |
| Nemaura Medical Inc. | 7.13 Million USD | -345.649% |
| NeuroPace, Inc. | 75.29 Million USD | 57.748% |
| LENSAR, Inc. | 33.33 Million USD | 4.566% |
| Apyx Medical Corporation | 51.01 Million USD | 37.642% |
| Cutera, Inc. | 197.72 Million USD | 83.91% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -28.381% |
| BioSig Technologies, Inc. | 28.53 Million USD | -11.511% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 83.385% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 11.775% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.196% |
| Axonics, Inc. | 270.2 Million USD | 88.226% |
| Outset Medical, Inc. | 198.77 Million USD | 83.995% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 82.347% |
| IRadimed Corporation | 30.12 Million USD | -5.614% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -272.879% |
| INVO Bioscience, Inc. | 7.85 Million USD | -305.104% |
| Telesis Bio, Inc. | 63.48 Million USD | 49.891% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 67.686% |
| Varex Imaging Corporation | 224.8 Million USD | 85.848% |
| Quipt Home Medical Corp. | 148.66 Million USD | 78.6% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -171.381% |
| Pulmonx Corporation | 112.68 Million USD | 71.768% |
| Dynatronics Corporation | 9.9 Million USD | -221.093% |
| Modular Medical, Inc. | 17.52 Million USD | -81.494% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -57.596% |
| Semler Scientific, Inc. | 38.94 Million USD | 18.308% |
| InMode Ltd. | 215.68 Million USD | 85.249% |
| Bruker Corporation | 1.07 Billion USD | 97.044% |
| Cytosorbents Corporation | 48.33 Million USD | 34.183% |
| DexCom, Inc. | 1.69 Billion USD | 98.119% |
| Align Technology, Inc. | 2.07 Billion USD | 98.468% |
| Viveve Medical, Inc. | 22.17 Million USD | -43.481% |
| ZimVie Inc. | 275.12 Million USD | 88.437% |
| Movano Inc. | 29.69 Million USD | -7.154% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 76.824% |
| Nexalin Technology, Inc. | 5.78 Million USD | -450.286% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -801.758% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 94.706% |
| Profound Medical Corp. | 33.6 Million USD | 5.324% |
| Insulet Corporation | 939.9 Million USD | 96.615% |
| enVVeno Medical Corporation | 25.23 Million USD | -26.056% |
| Surmodics, Inc. | 98.69 Million USD | 67.766% |
| iCAD, Inc. | 22.22 Million USD | -43.145% |
| Nuwellis, Inc. | 22.61 Million USD | -40.689% |
| Biotricity, Inc. | 17.18 Million USD | -85.131% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 92.865% |
| Aethlon Medical, Inc. | 12.27 Million USD | -159.124% |
| InspireMD, Inc. | 22.95 Million USD | -38.623% |
| PAVmed Inc. | 64.82 Million USD | 50.925% |
| BIOLASE, Inc. | 34.66 Million USD | 8.214% |
| Beyond Air, Inc. | 61.7 Million USD | 48.438% |
| FONAR Corporation | 28.6 Million USD | -11.22% |
| AxoGen, Inc. | 149.33 Million USD | 78.696% |
| Vivani Medical, Inc. | 26.96 Million USD | -17.983% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 82.035% |
| Inari Medical, Inc. | 448.59 Million USD | 92.908% |
| UFP Technologies, Inc. | 58.08 Million USD | 45.232% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -545.629% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -403.522% |
| Tenon Medical, Inc. | 16.96 Million USD | -87.494% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -330.326% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 27.864% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.049% |
| Sintx Technologies, Inc. | 15.2 Million USD | -109.289% |
| NanoVibronix, Inc. | 4.97 Million USD | -539.735% |
| Quanterix Corporation | 118.1 Million USD | 73.062% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -171.381% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -120.288% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 91.898% |
| TransMedics Group, Inc. | 182.82 Million USD | 82.598% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -13.358% |
| NeuroMetrix, Inc. | 11.09 Million USD | -186.64% |
| Hyperfine, Inc. | 52.87 Million USD | 39.828% |
| Establishment Labs Holdings Inc. | 172 Million USD | 81.504% |
| Biomerica, Inc. | 6.97 Million USD | -355.919% |
| Bone Biologics Corporation | 9.42 Million USD | -237.431% |
| AVITA Medical, Inc. | 80.77 Million USD | 60.616% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -208.538% |
| Silk Road Medical, Inc | 186.35 Million USD | 82.928% |